Advertisement
ProteinSimple
ProteinSimple

Tools and Strategies Driving Cancer Immunotherapy

The Scientist brings together a panel of experts who will delve into the hope and hype in an effort to educate the audience about the new findings in cancer immunotherapy.

By | February 20, 2014

 

FREE Webinar

Thursday March 20, 2014
2:30 - 4:00 p.m. Eastern Time
View The Video Now

A number of labs in the pharma/biotech industry and in academia are now focusing their efforts on new ways to modulate the immune system to target cancer. Advances, both in understanding immune pathways and in developing tools to target and exploit these pathways, have led to remarkable progress in this relatively new field. The Scientist brings together a panel of experts who will delve into the hope and hype in an effort to educate the audience about the new findings in cancer immunotherapy. Attendees can interact with the experts during the live webinar by asking questions and sharing their experiences on this topic.

Topics to be covered:

  • Basic concepts underlying immunomodulation for oncology
  • New drug entities: immunomodulatory agents, vaccines, monoclonal antibodies, and more
  • Challenges in drug development
  • New tools for screening and validation
  • Use of biomarkers for targeted therapies

View The Video Now

Meet the Speakers:

Dr. Jedd Wolchok
Chief, Melanoma & Immunotherapeutics Service
Memorial Sloan-Kettering Cancer Center

 

 

Dr. Tibor Keler
Senior Vice President and Chief Scientific Officer
Celldex Therapeutics

RocklandLonza

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Advertisement
Arbor Assays
Arbor Assays

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Simulating Scientific Sabotage, For Fun
  3. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
Advertisement
Life Technologies